Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetyla

Author:  ["Angela Taddei","Christèle Maison","Danièle Roche","Geneviève Almouzni"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

Histone modifications might act to mark and maintain functional chromatin domains during both interphase and mitosis. Here we show that pericentric heterochromatin in mammalian cells is specifically responsive to prolonged treatment with deacetylase inhibitors. These defined regions relocate at the nuclear periphery and lose their properties of retaining HP1 (heterochromatin protein 1) proteins. Subsequent defects in chromosome segregation arise in mitosis. All these changes can reverse rapidly after drug removal. Our data point to a crucial role of histone underacetylation within pericentric heterochromatin regions for their association with HP1 proteins, their nuclear compartmentalization and their contribution to centromere function.

Cite this article

Taddei, A., Maison, C., Roche, D. et al. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nat Cell Biol 3, 114–120 (2001). https://doi.org/10.1038/35055010

View full text

>> Full Text:   Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetyla

Lack of an endothelial store-operated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4−

A Ran-independent pathway for export of spliced mRNA